Literature DB >> 34171931

Conventional ultrasound for diagnosis of hepatic steatosis is better than believed.

Christoph F Dietrich1, Long Shi2, Axel Löwe1, Yi Dong3, Andrej Potthoff4, Zeno Sparchez5, Andreas Teufel6, Sabine Guth7, Jonas Koch1, Richard G Barr8, Xin-Wu Cui9.   

Abstract

BACKGROUND: Hepatic steatosis is a condition frequently encountered in clinical practice, with potential progression towards fibrosis, cirrhosis, and hepatocellular carcinoma. Detection and staging of hepatic steatosis are of most importance in nonalcoholic fatty liver disease (NAFLD), a disease with a high prevalence of more than 1 billion individuals affected. Ultrasound (US) is one of the most used noninvasive imaging techniques used in the diagnosis of hepatic steatosis. Detection of hepatic steatosis with US relies on several conventional US parameters, which will be described. US is the first-choice imaging in adults at risk for hepatic steatosis. The use of some scoring systems may add additional accuracy especially in assessing the severity of hepatic steatosis.
SUMMARY: In the presented paper, we discuss screening and risk stratification, ultrasound features for diagnosing hepatic steatosis, B-mode criteria, focal fatty patterns and Doppler features of the hepatic vessels, and the value of the different US signs for the diagnosis of liver steatosis including classifying the severity of steatosis using different US scores. Limitations of conventional B-mode and Doppler features in the evaluation of hepatic steatosis are also discussed, including those in grading and assessing the complications of steatosis, namely fibrosis and nonalcoholic steatohepatitis. KEY MESSAGES: Ultrasound is the first-line imaging examination for the screening and follow-up of patients with liver steatosis. The use of some scoring systems may add additional accuracy in assessing the severity of steatosis. Conventional B-mode and Doppler ultrasound have limitations in grading and assessing the complications of steatosis. Thieme. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 34171931     DOI: 10.1055/a-1491-1771

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN: 0044-2771            Impact factor:   1.769


  1 in total

1.  Effect of Phentermine on Hepatic Steatosis in Bariatric Surgery: A Pilot Study.

Authors:  Elizabeth Pérez-Cruz; Martha Guevara-Cruz; Salvador Ortiz-Gutiérrez; Yuritzy Luna-Camacho; Rafael Guzmán-Aguilar; Giuseppe Briceño-Sáenz; Luis González-Salazar; Adriana Flores-López
Journal:  Med Princ Pract       Date:  2022-05-06       Impact factor: 2.132

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.